Literature DB >> 17082582

Glutamate released by dendritic cells as a novel modulator of T cell activation.

Rodrigo Pacheco1, Harold Oliva, José M Martinez-Navío, Núria Climent, Francisco Ciruela, José M Gatell, Teresa Gallart, Josefa Mallol, Carmen Lluis, Rafael Franco.   

Abstract

Adaptive immune responses begin after productive immunosynaptic contacts formation established in secondary lymphoid organs by dendritic cells (DC) presenting the Ag to T lymphocytes. Despite its resemblance to the neurosynapse, the participation of soluble small nonpeptidic mediators in the intercellular cross-talk taking place during T cell-DC interactions remains poorly studied. In this study, we show that human DC undergoing maturation and in contact with T cells release significant amounts of glutamate, which is the main excitatory neurotransmitter in mammalians. The release of glutamate is nonvesicular and mediated by the DC-expressed Xc- cystine/glutamate antiporter. DC-derived glutamate stimulating the constitutively expressed metabotropic glutamate receptor 5 impairs T cell activation. However, after productive Ag presentation, metabotropic glutamate receptor 1 is expressed in T cells to mediate enhanced T cell proliferation and secretion of Th1 and proinflammatory cytokines. These data suggest that, during T cell-DC interaction, glutamate is a novel and highly effective regulator in the initiation of T cell-mediated immune responses.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17082582     DOI: 10.4049/jimmunol.177.10.6695

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  54 in total

1.  Differential dependence on cysteine from transsulfuration versus transport during T cell activation.

Authors:  Sanjay K Garg; Zhonghua Yan; Victor Vitvitsky; Ruma Banerjee
Journal:  Antioxid Redox Signal       Date:  2010-12-02       Impact factor: 8.401

Review 2.  Immune dysfunction in autism: a pathway to treatment.

Authors:  Milo Careaga; Judy Van de Water; Paul Ashwood
Journal:  Neurotherapeutics       Date:  2010-07       Impact factor: 7.620

Review 3.  Antineuronal antibodies against neurotransmitter receptors and synaptic proteins in schizophrenia: current knowledge and clinical implications.

Authors:  Johann Steiner; Kolja Schiltz; Hans-Gert Bernstein; Bernhard Bogerts
Journal:  CNS Drugs       Date:  2015-03       Impact factor: 5.749

4.  System xc⁻ cystine/glutamate antiporter: an update on molecular pharmacology and roles within the CNS.

Authors:  Richard J Bridges; Nicholas R Natale; Sarjubhai A Patel
Journal:  Br J Pharmacol       Date:  2012-01       Impact factor: 8.739

5.  Sustained calcium signalling and caspase-3 activation involve NMDA receptors in thymocytes in contact with dendritic cells.

Authors:  P Affaticati; O Mignen; F Jambou; M-C Potier; I Klingel-Schmitt; J Degrouard; S Peineau; E Gouadon; G L Collingridge; R Liblau; T Capiod; S Cohen-Kaminsky
Journal:  Cell Death Differ       Date:  2010-06-25       Impact factor: 15.828

6.  Monitoring diffuse injury during disease progression in experimental autoimmune encephalomyelitis with on resonance variable delay multiple pulse (onVDMP) CEST MRI.

Authors:  Aline M Thomas; Jiadi Xu; Peter A Calabresi; Peter C M van Zijl; Jeff W M Bulte
Journal:  Neuroimage       Date:  2019-10-09       Impact factor: 6.556

Review 7.  The neurotransmitter glutamate and human T cells: glutamate receptors and glutamate-induced direct and potent effects on normal human T cells, cancerous human leukemia and lymphoma T cells, and autoimmune human T cells.

Authors:  Yonatan Ganor; Mia Levite
Journal:  J Neural Transm (Vienna)       Date:  2014-03-02       Impact factor: 3.575

8.  Increased alpha-defensins 1-3 production by dendritic cells in HIV-infected individuals is associated with slower disease progression.

Authors:  Marta Rodríguez-García; Núria Climent; Harold Oliva; Víctor Casanova; Rafael Franco; Agathe Leon; José M Gatell; Felipe García; Teresa Gallart
Journal:  PLoS One       Date:  2010-02-25       Impact factor: 3.240

9.  Protection from fatal viral encephalomyelitis: AMPA receptor antagonists have a direct effect on the inflammatory response to infection.

Authors:  Ivorlyne P Greene; Eun-Young Lee; Natalie Prow; Brownhilda Ngwang; Diane E Griffin
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-22       Impact factor: 11.205

10.  Upregulation of serotonin transporter by alcohol in human dendritic cells: possible implication in neuroimmune deregulation.

Authors:  Dakshayani Kadiyala Babu; Alain Diaz; Thangavel Samikkannu; Kurapati V K Rao; Zainulabedin M Saiyed; Jose W Rodriguez; Madhavan P N Nair
Journal:  Alcohol Clin Exp Res       Date:  2009-07-01       Impact factor: 3.455

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.